Related Experiment Videos
[Invasive cervical carcinoma coexistent with pregnancy]
Ginekologia Polska
|July 1, 1989
Summary
Treatment for invasive cervical carcinoma during pregnancy yielded a 5-year survival rate of 28.6%. Early-stage cancers in early pregnancy showed the best outcomes, while those diagnosed postpartum had no survivors.
Area of Science:
- Oncology
- Gynecology
- Radiation Oncology
Context:
- Invasive cervical carcinoma coexisting with pregnancy presents unique treatment challenges.
- Management requires careful consideration of FIGO staging and gestational stage.
Purpose:
- To evaluate treatment outcomes for invasive cervical carcinoma diagnosed during pregnancy.
- To identify prognostic factors influencing survival in this patient cohort.
Summary:
- This study analyzed 28 cases of invasive cervical carcinoma in pregnant patients, treated with surgery and radiotherapy (brachytherapy and teletherapy) based on FIGO staging.
- Overall, 28.6% (8 patients) achieved a 5-year survival.
- Optimal outcomes were observed in patients with early-stage (FIGO grade I) disease diagnosed early in pregnancy. No patients diagnosed postpartum survived 5 years.
Impact:
- Highlights the importance of early diagnosis and treatment for improving survival rates in pregnant patients with cervical cancer.
- Informs clinical decision-making regarding multimodal treatment strategies for this rare condition.
- Underscores the critical prognostic role of disease stage and timing of diagnosis relative to pregnancy and delivery.